Skip to main content

Table 2 Patients at high risk in primary prevention

From: From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial

  Complex intervention A n = 675 Simple intervention B n = 649 A vs. B
  Mean FU 95% CI Mean FU 95% CI Difference/Odds ratio 95% CI p ICC p
CVR 13.0% 12.5%-13.6% 12.5% 11.9%-13.1% Δ = 0.5% -0.3%-1.3% 0.197 0.029 0.004
RR systolic [mmHg] 138.0 136.4-139.7 137.3 135.6-139.1 Δ = 0.7 -1.7-3.1 0.563 0.082 <0.001
RR diastolic [mmHg] 80.5 79.6-81.4 80.0 79.0-80.9 Δ = 0.5 -0.8-1.8 0.461 0.078 <0.001
Control rate RR < 140/90 46.7% 40.4%-53.1% 46.9% 40.3%-53.5% OR = 0.99 0.68-1.45 0.966 0.128 <0.001
Control rate RR < 160/95 86.8% 83.1%-90.6% 88.9% 85.4%-92.3% OR = 0.82 0.51-1.31 0.405 0.141 <0.001
Cholesterol [mg/dl] 221.9 219.1-224.6 220.9 218.1-223.7 Δ = 1.0 -3.0-4.93 0.634 0.015 0.085
Current smoker 12.0% 9.7%-14.4% 14.4% 11.9%-17.0% OR = 0.71 0.44-1.16 0.171 0.093 0.019
ASS 21.4% 19.1%-23.7% 23.9% 21.0%-26.8% OR = 0.67 0.37-1.19 0.172 0.206 <0.001
Statins 23.3% 19.7%-26.9% 19.4% 15.8%-23.0% OR = 1.52 0.89-2.62 0.128 0.206 <0.001
  1. Outcomes at follow up in subpopulation at high CVR (10-year mortality ≥ 5%), but no manifest CVD (complete cases), adjusted for baseline and taking cluster effects into account by use of a mixed model.